Search

Search Constraints

You searched for: Author/Creator Atreya, R.

Search Results

1. OC.12.4 EXTENT OF MUCOSAL INFLAMMATION IN ULCERATIVE COLITIS INFLUENCES THE CLINICAL RESPONSE TO VEDOLIZUMAB. (1st October 2020)

3. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016)

4. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease – a prospective multicenter observational study. Issue 11 (7th October 2016)